Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clement Chung

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 7, 2022
Targeting the androgen receptor signaling pathway in advanced prostate cancerClement Chung, Karen Abboud
Pharmacotherapy|October 31, 2014
Ibrutinib, obinutuzumab, idelalisib, and beyond: review of novel and evolving therapies for chronic lymphocytic leukemiaClement Chung, Rosetta Lee
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 16, 2013
Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendationClement Chung, Matthew Christianson
European Journal of Haematology|March 11, 2025
Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic StrategyClement Chung, David Doan
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 1, 2016
An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesisClement Chung, Rosetta Lee
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 1, 2015
Trametinib: a novel signal transduction inhibitor for the treatment of metastatic cutaneous melanomaClement Chung, Sean Reilly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 17, 2013
Ziv-aflibercept: a novel angiogenesis inhibitor for the treatment of metastatic colorectal cancerClement Chung, Nisha Pherwani
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 18, 2025
Rising with cardio-oncology: Clinical considerations of cardiotoxicity with select anticancer drug therapiesClement Chung, Katelynn Tran
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 5, 2024
Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendationClement Chung, Godsfavour Umoru
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 31, 2013
Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancerClement Chung, Masha S H Lam
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 7, 2022
Targeting the androgen receptor signaling pathway in advanced prostate cancerClement Chung, Karen Abboud
Pharmacotherapy|October 31, 2014
Ibrutinib, obinutuzumab, idelalisib, and beyond: review of novel and evolving therapies for chronic lymphocytic leukemiaClement Chung, Rosetta Lee
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 16, 2013
Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendationClement Chung, Matthew Christianson
European Journal of Haematology|March 11, 2025
Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic StrategyClement Chung, David Doan
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 1, 2016
An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesisClement Chung, Rosetta Lee
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 1, 2015
Trametinib: a novel signal transduction inhibitor for the treatment of metastatic cutaneous melanomaClement Chung, Sean Reilly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 17, 2013
Ziv-aflibercept: a novel angiogenesis inhibitor for the treatment of metastatic colorectal cancerClement Chung, Nisha Pherwani
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 18, 2025
Rising with cardio-oncology: Clinical considerations of cardiotoxicity with select anticancer drug therapiesClement Chung, Katelynn Tran
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 5, 2024
Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendationClement Chung, Godsfavour Umoru
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 31, 2013
Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancerClement Chung, Masha S H Lam
Pageof 5